Nurith Aizenman
[Copyright 2024 NPR]
-
In the United States there's lots of discussion about when the coronavirus will finally become endemic the way colds are. But African scientists say that may have already happened on their continent.
-
The program called COVAX was set up to make sure that all countries have access to COVID vaccines. Two key public health figures talk about what went wrong — and how to fix it.
-
COVAX was set up to enable global access to vaccines against COVID. Yet nearly 80 countries will miss a target of vaccinating 40% of their populations by year's end. Here's what went wrong.
-
With Omicron surging, the U.K.'s government is hoping to stave off hospitalizations and deaths through a massive effort to administer vaccine boosters. But the strategy faces major hurdles in the U.S.
-
How did this new strain of the coronavirus evolve? Researchers are investigating various possibilities. One leading theory involves ... just one person.
-
How did the coronavirus end up mutating into the omicron variant? One hypothesis is that it spent months replicating in the body of someone whose immune system was suppressed by uncontrolled HIV.
-
Pharmaceutical companies Pfizer and Merck have agreed to allow generic manufacturers to make inexpensive versions of their anti-viral pills to treat COVID-19.
-
There's been a massive ramp up in production of COVID-19 vaccines. Yet low income nations still aren't getting enough. Analysts say it's because wealthy countries are buying way more than they need.
-
It's the first step in an audacious plan to solve vaccine inequity by setting up the manufacturing of mRNA vaccines across low-resource countries.
-
A consortium in South Africa wants to teach manufacturers in poor countries to make Moderna's COVID vaccine. But Moderna won't share its process. So the scientists are trying to reverse engineer it.